U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07064499) titled 'CGM Boosted by Artificial Intelligence for Better Glycaemic Control in T2 Diabetes' on July 11.
Brief Summary: Title: CGM Boosted by Artificial Intelligence for better glycaemic control in T2 Diabetes : a real-life multicenter observational study in Belgium - MAGIC-T2D
Background: In Belgium, since May 2023, reimbursement for continuous glucose monitoring systems has been extended to people with type 2 diabetes taking multiple injections of insulin. Despite the results of previous studies, the impact of this technology in terms of glycaemic control and patient-reported outcomes (PROMs) in real life for patients with type 2 diabetes...